Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amifampridine for Post-Botox Vocal Weakness in Spasmodic Dysphonia
NCT05123053Phase 2Completed
- Sponsor
- Augusta University
- Start
- Oct 2021
- Primary completion
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of amifampridine in vocal cord paresis, sponsored by Augusta University. Started Oct 2021; status: completed.
02
Drugs
amifampridine
03
Conditions
vocal cord paresis
Beyond the preview
Go deeper on NCT05123053.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05123053.